Divi's Laboratories (NSE:DIVISLAB) Short-Term Debt : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Short-Term Debt?

Divi's Laboratories's Short-Term Debt for the quarter that ended in Dec. 2023 was ₹0 Mil.

Divi's Laboratories's quarterly Short-Term Debt increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹20 Mil) but then declined from Sep. 2023 (₹20 Mil) to Dec. 2023 (₹0 Mil).

Divi's Laboratories's annual Short-Term Debt declined from Mar. 2021 (₹4 Mil) to Mar. 2022 (₹0 Mil) but then stayed the same from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil).

Divi's Laboratories Short-Term Debt Historical Data

The historical data trend for Divi's Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Short-Term Debt Chart

Divi's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Short-Term Debt

Get a 7-Day Free Trial

1,056.00

336.30

3.50

Divi's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	20.00	-

Divi's Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Divi's Laboratories Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories (NSE:DIVISLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Short-Term Debt

Traded in Other Exchanges

532488:India

Address

Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines